Oral anticoagulants in older adults with atrial fibrillation


Journal Article

Atrial fibrillation (AF) is the most common arrhythmia in adults and contributes directly to adverse clinical events, ranging from ischemic stroke to heart failure and cardiovascular death. Because the incidence of AF and its attendant complications increase with age, there is a strong and growing need to develop safe, effective and widely available therapies. The following review summarizes the use of oral anticoagulants in older adults with AF, focusing on practical topics such as drug metabolism, drug-drug interactions, co-morbidities and cost considerations in a complex payer environment. © 2013 Springer Science+Business Media New York.

Full Text

Duke Authors

Cited Authors

  • Bernacki, GM; Becker, RC

Published Date

  • November 1, 2013

Published In

Volume / Issue

  • 36 / 4

Start / End Page

  • 403 - 415

Electronic International Standard Serial Number (EISSN)

  • 1573-742X

International Standard Serial Number (ISSN)

  • 0929-5305

Digital Object Identifier (DOI)

  • 10.1007/s11239-013-0869-0

Citation Source

  • Scopus